Chemical Executives Deal with Tariffs (ICIS Chemical Business May 9 – May 15, 2025)Jonathan Choi2025-05-09T18:28:48+00:00May 9th, 2025|Featured, Our Publications|
Chemical Debt Financing Perks Up (ICIS Chemical Business February 21 – February 27, 2025)Jonathan Choi2025-03-04T15:14:26+00:00February 21st, 2025|Featured, Our Publications|
Biopharma Business Check – Financing and Review (Pharmaceutical Executive, February 2025)Jonathan Choi2025-02-17T18:02:53+00:00February 7th, 2025|Featured, Our Publications|
Global M&A Treads WaterJonathan Choi2025-02-17T17:56:46+00:00February 7th, 2025|Featured, Our Publications|
Divestitures in the Current EnvironmentJonathan Choi2025-02-05T22:23:10+00:00January 28th, 2025|Featured, Our Publications|
Reflections on 2024 and Outlook – Stock Market and FundingJonathan Choi2025-02-05T22:13:34+00:00January 28th, 2025|Featured, Our Publications|
Reflections on 2024 and Outlook – Senior Management Approach to M&AJonathan Choi2025-02-05T22:09:34+00:00January 28th, 2025|Featured, Our Publications|
Reflections on 2024 and Outlook – Biotech and Pharma M&AJonathan Choi2025-02-05T22:03:00+00:00January 28th, 2025|Featured, Our Publications|
Young & Partners Pharmaceutical Executive Summit 2024: The Impact of Artificial Intelligence on the Creation of Medicines (Pharmaceutical Executive)Jonathan Choi2024-11-06T21:10:32+00:00October 24th, 2024|Featured, Our Publications|
Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading? (Pharmaceutical Executive)Jonathan Choi2024-11-06T21:10:53+00:00October 23rd, 2024|Featured, Our Publications|
